Cancer Tech Startup Ezra Raised $18 Million Right Before The Pandemic, Now It’s Pivoting To Covid-19 Screening

After the coronavirus lockdown froze its cancer screening business, startup Ezra has shifted focus to testing for Covid-19 damage.